Curated News
By: NewsRamp Editorial Staff
August 26, 2026
Lonza Appoints Samanta Cimitan as Chief Commercial Officer to Drive One Lonza Strategy
TLDR
- Lonza appoints Samanta Cimitan as CCO to strengthen customer engagement and gain a competitive edge in the CDMO market.
- Cimitan will lead strategic account management, marketing, and commercial excellence, unifying go-to-market across all business platforms by January 2027.
- This move aims to make it easier for pharma partners to access Lonza's capabilities, ultimately helping bring life-saving therapies to patients faster.
- Samanta Cimitan returns to Lonza after 13 years, having led Celonic Group, bringing valuable CDMO insight to her new role.
Impact - Why it Matters
This appointment signals Lonza's intensified focus on commercial excellence and customer-centricity, which could lead to more streamlined partnerships and faster development of therapies for patients. By unifying its go-to-market approach, Lonza aims to make its vast capabilities more accessible to pharma and biotech innovators, potentially accelerating the delivery of life-saving medicines. For industry observers, this move reflects a broader trend of CDMOs investing in leadership to meet evolving client needs and enhance competitiveness.
Summary
Lonza, the world's leading contract development and manufacturing organization (CDMO), has announced the appointment of Samanta Cimitan as Chief Commercial Officer (CCO), Senior Vice President, and Member of the Extended Executive Committee, effective by 1 January 2027. This newly created role underscores Lonza's commitment to its One Lonza strategy, aimed at unifying its commercial approach and enhancing customer engagement across its global operations. Cimitan, who currently serves as CEO of the Celonic Group, brings extensive business leadership experience in the CDMO industry. She previously spent nearly 13 years at Lonza in commercial and strategy roles, including Vice President of Group Operations Strategy. Her return is seen as a strategic move to leverage her deep understanding of Lonza's capabilities and her proven track record in commercial strategy and customer partnerships.
In her new position, Cimitan will lead Strategic Enterprise Account Management, Global Marketing, and Commercial Excellence, with direct responsibility for Lonza's strategic accounts. She will help shape a harmonized go-to-market approach across all three business platforms, making it easier for customers to access Lonza's full end-to-end offering. Wolfgang Wienand, CEO of Lonza, expressed enthusiasm about Cimitan's appointment, highlighting her CDMO expertise and leadership skills. He emphasized that this step is crucial for building One Lonza and ensuring that every customer benefits from Lonza's science, technology, and manufacturing capabilities.
The announcement comes as Lonza continues to strengthen its commercial focus, with a goal to deliver on its purpose of making medicines of tomorrow. Cimitan's role is part of a broader strategy to enhance customer engagement and drive growth. Lonza, with approximately 20,000 employees across five continents, reported sales of CHF 3.4 billion and CORE EBITDA of CHF 1.2 billion in the first half of 2026. The company's commitment to innovation and partnerships remains steadfast, as it collaborates with pharma and biotech firms to translate breakthroughs into viable therapies. For more details, visit NEWMEDIAWIRE.
Source Statement
This curated news summary relied on content distributed by NewMediaWire. Read the original source here, Lonza Appoints Samanta Cimitan as Chief Commercial Officer to Drive One Lonza Strategy
